The management of neonatal erythroderma is difficult group because this condition has many possible underlying causes. Many of the affected children experience a chronic benign course, but immunodeficiencies can lead to complications and death if not treated on time.
The main objective of the study is to find a definite diagnosis in a short time before complications occur. The best treatment can then start.
Through this study we hope to obtain more detailed information about patients with neonatal erythroderma and collodion babies that can help us finding a diagnosis fast, preferably within two weeks.